1-401-861-5900
The Original Thin Dense Chrome
Since 1945

Medical

ELECTROLIZING® FOR MEDICAL DEVICES

Since 1992 Electrolizing® has housed its sister company ME-92 Operations, Inc. in the same Providence, RI production facility. ME-92 Operations specializes in industry-leading biocompatible coatings for medical tools and devices, offering both the ME-92® coating and the biocompatible version of the AL-COAT® coating specifically suited to medical applications.

THE ME-92 COATINGS IMPROVE THE PERFORMANCE, DURABILITY AND APPEARANCE OF MEDICAL TOOLS AND EQUIPMENT

ME-92® coatings are precise, biocompatible, and pure metallic chromium coatings for medical, surgical, laboratory, and clean room environments. Highly trained coating professionals and strict process controls allow for a uniform coating that is unparalleled in performance.

The coatings are completely inert, non-magnetic, and USP 10993-10, 10993-6, and 10993-11 tested. It may also interest you to know that Electrolizing® has a sister company, ME-92®, that specializes in biocompatible chromium coatings that were developed for application in the medical device industry.

KEY BENEFITS

  • Arrests corrosion from sterilization and laser marking while maintaining new appearance
  • Increases wear resistance
  • Maintains cutting edges
  • Provides a hard, scratch resistant, nonstick, and easy clean surface
  • Increases surface hardness
  • Eliminates galling, fretting, and spalling
  • Ability to easily remove and reapply
  • Arrests metallic debris and particulate matter
  • Provides smooth sliding surfaces
  • Reduces high intensity light reflection/refraction and glare
  • Provides a long lasting, clean, pristine, and new appearance
  • Chemical and detergent resistant
  • Hydrophobic

ME-92® MEDICAL DEVICE TESTING SPECIFICATIONS

ME-92 Operations abides by strict testing requirements that meet the needs of the medical device community. Here is a list of our testing capabilities.

  • Hydrogen Embrittlement – per ASTM F519
  • Salt Spray (50 hour) – per ASTM B117
  • Adhesion – per ASTM B571 and BAC5709
  • Hardness – per ASTM E384-17 and BAC5709
  • Porosity – per AMS 2460
  • NAMSA per USP 10993-10, 10993-6, and 10993-11
  • Custom testing available per customer specifications

As mentioned, we are able to work with our customers to provide any additional testing requirements.

CONTACT ELECTROLIZING® TODAY 

As you can see there are many advantages and reasons to invest in Electrolizing’s chromium coating for medical devices. Contact us to learn more.

CONTACT US

NAMSA Test Results:

United States Pharmacopeia; ISO 10993-10
USP Intracutaneous Study
TU013-800
No Localized Tissue Reaction
Irritation tests are utilized to assess the irritation potential of medical devices, bio-materials, or their extracts exposed to eye, skin, or mucous membranes. The test(s) are performed using a model appropriate for the route (skin, eye, mucosa) and duration of exposure or contact.
United States Pharmacopeia; ISO 10993-6
USP Muscle Implantation Study 7 Day
TU014-807
Non Irritating to Muscle Tissue
Implantation tests are performed to evaluate the local d pathological effects on living tissue, at both the gross level and microscopic level, after implantation of samples of medical Implantation tests are performed to evaluate the local pathological effects on living tissue, at both the gross level and microscopic level, after implantation of samples of medical devices or bio-materials. The implant location is based on the clinical site of use. Implant duration’s are based on the need to evaluate the tissue response over multiple intervals and along with the sample’s inertness and absorptive characteristics.
U.S. Pharmacopeial Convention; ISO 10993-11
Acute Systemic - No Systemic Toxicity
TU012-500
No Systemic Toxicity
Systemic Toxicity tests evaluate the generalized biological effects to organs and tissues following exposure to a medical devices, bio-material, or their extracts. The term systemic implies that the exposure occurs by one route and the toxic substance is carried to distant locations causing an adverse effect. Systemic toxicity is typically evaluated in studies of acute, sub-acute, sub-chronic, and chronic duration based on the device’s intended exposure.
The Electrolizing® coating technology was developed in 1945 in Providence, RI. For over 75 years, Electrolizing, Inc. has consistently refined our process to keep it the most advanced ultra-pure...... Learn More
The MICRO-E® coating is an engineering extension of the Electrolizing® coating. MICRO-E® incorporates a multi-step cleaning process along with modified coating application techniques that result... Learn More
AL-COAT® was developed to meet the challenge of protecting aluminum alloys. This technologically advanced coating provides a dense, non-magnetic, high chromium alloy deposited directly... Learn More

ISO 9001-2015 CERTIFIED

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanhi Hindiit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish